MEDG.F Stock Overview
Develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Medacta Group SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 83.91 |
| 52 Week High | CHF 124.00 |
| 52 Week Low | CHF 83.91 |
| Beta | 1.2 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -2.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEDG.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.7% | 0.3% |
| 1Y | n/a | 21.4% | 31.1% |
Return vs Industry: Insufficient data to determine how MEDG.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how MEDG.F performed against the US Market.
Price Volatility
| MEDG.F volatility | |
|---|---|
| MEDG.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MEDG.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MEDG.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 1,421 | Francesco Siccardi | www.medacta.com |
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Medacta Group SA Fundamentals Summary
| MEDG.F fundamental statistics | |
|---|---|
| Market cap | US$2.18b |
| Earnings (TTM) | US$50.44m |
| Revenue (TTM) | US$422.29m |
43.2x
P/E Ratio5.2x
P/S RatioIs MEDG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDG.F income statement (TTM) | |
|---|---|
| Revenue | €396.91m |
| Cost of Revenue | €115.91m |
| Gross Profit | €281.00m |
| Other Expenses | €233.59m |
| Earnings | €47.41m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Mar 17, 2023
| Earnings per share (EPS) | 2.37 |
| Gross Margin | 70.80% |
| Net Profit Margin | 11.94% |
| Debt/Equity Ratio | 57.8% |
How did MEDG.F perform over the long term?
See historical performance and comparison